Skip to main content

Table 3 Summary of HR for PFS by Age

From: Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis

Age HR (95% CI)
Age < 65 years 0.73 (0.61 to 0.88)
Age ≥ 65 years 0.74 (0.60 to 0.92)